Taunia Markvicka Email Address

Senior Vice President and Chief Commercial Officer

Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL(r) (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam(r), a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

Influential leader in marketing, new product planning, and commercial management with a track record of identifying, developing, launching and marketing pharmaceutical products. Recognized for turning market and customer insights into valuable strategy and actionable marketing plans and leading customer facing organization to deliver the corporate mission. Expansive leadership background that includes building, developing and leading high-performing teams and delivering strategic commercial leadership to drive critical large-scale projects/programs towards market success. Career reputation as an innovative leader who consistently creates landmark new standards for organizations. SPECIALTY MARKETS OF EXPERTISE: Oncology supportive care, pain, cardiovascular, neurology, women’s health, dermatology, diabetes, infectious diseases/antibiotics, urology, postsurgical pain, addiction/opioid addiction management, immunology.